The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Implementing combinatorial immunotherapeutic regimens against cancer
Team | IMMEI
Dr. Annkristin Heine, MD
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
Researchers release the brakes on the immune | EurekAlert!
Two cases of EBV infection preceding lymphoma | SpringerLink
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Team | IMMEI
UKB NewsRoom | Annkristin Heine
CIO Bonn - Lymphomzentrum
ImmunoSensation / The Immune Sensory System » Details
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
Medicine®
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
